sb 203580 has been researched along with vasoactive intestinal peptide in 2 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (vasoactive intestinal peptide) | Trials (vasoactive intestinal peptide) | Recent Studies (post-2010) (vasoactive intestinal peptide) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 10,873 | 123 | 1,221 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Denis, MG; Galmiche, JP; Jarry, A; Laboisse, CL; Neunlist, M; Oreshkova, T; Toumi, F | 1 |
| Chen, LM; Li, CY; Ren, XH; Xu, YH; Yu, XJ; Zhou, CL | 1 |
2 other study(ies) available for sb 203580 and vasoactive intestinal peptide
| Article | Year |
|---|---|
Vasoactive intestinal peptide induces IL-8 production in human colonic epithelial cells via MAP kinase-dependent and PKA-independent pathways.
Topics: Cell Polarity; Colon; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epithelial Cells; Flavonoids; HT29 Cells; Humans; Imidazoles; Interleukin-8; Intestinal Mucosa; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Protein Serine-Threonine Kinases; Pyridines; RNA, Messenger; Vasoactive Intestinal Peptide | 2004 |
Vasoactive intestinal peptide induces vascular endothelial growth factor production in human HaCaT keratinocytes via MAPK pathway.
Topics: Blotting, Western; Cell Line; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Flavonoids; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Keratinocytes; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Vascular Endothelial Growth Factor A; Vasoactive Intestinal Peptide | 2010 |